片仔癀：2亿元参投招盈慧康基金完成备案，圆山计划再迈步

Group 1 - The company, Pianzaihuang, has announced its investment in the Zhaoying Huikang Fund, contributing 200 million yuan, which represents 20% of the fund [1] - The investment is part of the company's strategic development plan, aimed at enhancing its competitiveness in the pharmaceutical industry by leveraging professional investment resources [1] - The fund will primarily invest in sectors such as biomedicine, traditional Chinese medicine, medical devices, consumer healthcare, and medical services [1] Group 2 - The Zhaoying Huikang Fund is a component of the "Yuanshan Plan," initiated by Zhangzhou to promote the development of the traditional Chinese medicine industry and facilitate cross-strait integration in healthcare [2] - Pianzaihuang is identified as a key enterprise in the implementation of the "Yuanshan Plan," which includes the establishment of six funds totaling 6 billion yuan [2] - The successful registration of the Zhaoying Huikang Fund marks it as the third fund to complete the process under the Yuanshan medical health fund initiative, with additional funds in progress [2]